Evaluation of inaccuracies in the measurement of glycemia in the laboratory, by glucose meters, and through measurement of hemoglobin A 1c

Clinical Diabetes

Volumn 25, Issue 2, 2007, Pages 43-49

  Schrot, Richard J ^a   Patel, Kirit T ^b   Foulis, Philip ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b QUEST DIAGNOSTICS NICHOLS INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; ISOPHANE INSULIN; METFORMIN; ROSIGLITAZONE;

BLOOD SAMPLING; CARDIOVASCULAR RISK; DIABETES MELLITUS; DIAGNOSTIC TEST; ERYTHROCYTE; GLUCOSE ASSAY; GLUCOSE BLOOD LEVEL; HEMOGLOBINOPATHY; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; LABORATORY TEST; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; PRIMARY MEDICAL CARE; REVIEW;

EID: 34248362441     PISSN: 08918929     EISSN: None     Source Type: Journal    
DOI: 10.2337/diaclin.25.2.43     Document Type: Review

References (38)

1. The DCCT Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977-986, 1993
2. U.K. Prospective Diabetes Study Group: Intensive blood-glucose control with sulfonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes. Lancet 352:837-853, 1998
3. The DCCT/EDIC Study Research Group: Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med 353:2643-2653, 2005
4. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 20: 1183-1197, 1997.
5. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus: Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 26:3160-3167, 2003
6. Diabetes Prevention Program Research Group: Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 346:393-403, 2002
7. National Diabetes Data Group: Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 28:1039-1057, 1979
8. Sacks D, Bruns D, Goldstein D, Mackaren N, McDonald J, Parrott M: Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. Clin Chem 48:436-472, 2002
9. Schwartz J, Reichberg S, Gambino R: Glucose testing variability and the need for an expert oversight committee [article online]. CAP Today May 2005. Available from http://www.cap.org/apps/docs/cap_today/feature_stories/ 0505Commentary.html
10. Nichols J: What is accuracy and how close must agreement be? Diabetes Technol Therapeut 7:558-562, 2005
11. Clarke L, Cox D, Goder-Frederick L, Carter W, Pohl S: Evaluating clinical accuracy of systems for self-monitoring of blood glucose. Diabetes Care 10:622-628, 1987
12. Skeie S, Thue G, Nerhus K, Sandberg S: Instruments for self-monitoring of blood glucose: comparisons of testing quality achieved by patients and a technician. Clin Chem 48:994-1003, 2002
13. Kollman C, Wilson D, Wysocki T, Tamborlane W, Beck R: Limitations of statistical measures of error in assessing the accuracy of continuous glucose sensors. Diabetes Technol Therapeut 7:665-672, 2005
14. Kulcu E, Tamada J, Reach G, Potts R, Lesho M: Physiological differences between interstitial glucose and blood glucose measured in human subjects. Diabetes Care 26:2405-2409, 2003
15. Saudek C, Derr R, Kalyani R: Assessing glycemia in diabetes using self-monitoring of blood glucose and hemoglobin A1C. JAMA 295:1688-1697, 2006
16. Venes D (Ed.): Taber's Cyclopedic Medical Dictionary. 19th ed. Philadelphia, PA, F.A. Davies, 2001, p. 1601-1602 and 1876.
17. Ollerton R, Playle R, Ahmed K, Dunstan F, Luzio S, Owens D: Day to day variability of fasting plasma glucose in newly diagnosed type 2 diabetic subjects. Diabetes Care 22:394-398, 1999
18. Troisi R, Cowie C, Harris M: Diurnal variation in fasting plasma glucose: implications for diagnosis of diabetes in patients examined in the afternoon. JAMA 284:3157-3159, 2000
19. American Diabetes Association: Consensus statement on self-monitoring of blood glucose. Diabetes Care 10:93-99, 1987
20. American Diabetes Association: Consensus statement on self-monitoring of blood glucose. Diabetes Care 17:81-86, 1994
21. American Diabetes Association: Self-monitoring of blood glucose. Diabetes Care 19 (Suppl. 1):S62-S66, 1996
22. Lewandrowski K, Cheek R, Nathan D: Implementation of capillary blood glucose monitoring in a teaching hospital and determination of program requirements to maintain quality testing. Am J Med 93:419-426, 1992
23. Johnson R, Baker J: Error detection and measurement in glucose monitors. Clini Chim Acta 307:61-67, 2001
24. American Diabetes Association: Tests of glycemia in diabetes. Diabetes Care 27 (Suppl. 1):S91-S93, 2004
25. American Diabetes Association: Standards of medical care in diabetes 2006. Diabetes Care 29 (Suppl. 1):S4-S42, 2006
26. Finkielman J, Oyen L, Afessa B: Agreement between bedside blood and plasma glucose measurement in the ICU setting. Chest 127:1749-1751, 2005
27. Binette T, Cembrowski G: Diverse influences of blood glucose measurements in the ICU setting. Chest 128:3084-3085, 2005
28. Diabetes Research in Children Network Study Group: Accuracy of the GlucoWatch G2 Biographer and the continuous glucose monitoring system during hypoglycemia. Diabetes Care 27:722-726, 2004
29. Kovatchev B, Gonder-Frederick L, Cox D, Clarke W: Evaluating the accuracy of continuous glucose-monitoring sensors. Diabetes Care 27:1922-1928, 2004
30. LifeScan Corporation: FDA clears new labeling guidelines for alternate site testing option with LifeScan blood glucose monitoring products (Press Release). 17 December 2001. Available online from http://www.jnj.com/news/ jnj_news/20020404_0933.htm;jsessionid=GAOK2WD2YRCOK
31. Lock J, Szuts E, Malomo K, Anagnostopoulos A: Whole-blood glucose testing at alternate sites. Diabetes Care 25:337-341, 2002
32. Diabetes Research in Children Network Study Group: Accuracy of new-generation home blood glucose meters in a Diabetes Research in Children Network inpatient exercise study. Diabetes Technol Therapeut 7:675-680, 2005
33. Clarke W, Anderson S, Farhy L, Breton M, Gonder-Frederick L, Cox D, Kovatchev B: Evaluating the clinical accuracy of two continuous glucose sensors using continuous glucose error grid analysis. Diabetes Care 28:2412-2417, 2005
34. Rohlfing C, Wiedmeyer H, Little R, England J, Tennill A, Goldstein D: Defining the relationship between plasma glucose and HbA1C. Diabetes Care 25:275-278, 2002
35. Tseng C, Brimacombe M, Xie M, Rajan M, Wang H, Kolassa J, Crystal S, Chen T, Pogach L, Safford M: Seasonal patterns in monthly hemoglobin A1C values. Am J Epidemiol 161:565-574, 2005
36. Bry L, Chen P, Sacks D: Effects of hemoglobin variants and chemically modified derivatives on assays for glycohemoglobin. Clin Chem 47:153-163, 2001
37. Jeppsson J, Kobold U, Barr J: Approved IFCC reference method for the measurement of HbA1c in human blood. Clin Chem Lab Med 40:78-89, 2002
38. Kilpatrick E: HbA1c measurement. J Clin Pathol 57:344-345, 2004